Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Disc Medicine, Inc.IRON · Entity 2273 | Chief Medical Officer | April 13, 2026 | April 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Disc Medicine, Inc.
Report date April 13, 2026 · Filed April 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,480 |
Ending reported balance
After 2026-04-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-13 · Sale · Disposed 3,531 · Balance 81,680 F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Row 2 · 2026-04-13 · Sale · Disposed 2,200 · Balance 79,480 F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2026 Filed Apr 15, 2026 21:05 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,200 | $66.81 | $146,976.06 |
DisclosureSEC source: 0001193125-26-157215 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,480 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 21:05 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,531 | $66.12 | $233,472.90 |
DisclosureSEC source: 0001193125-26-157215 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,680 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:55 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,986 | $66.41 | $198,297.27 |
DisclosureSEC source: 0001193125-26-091757 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,211 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.03 to $66.88, inclusive. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:55 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 4,392 | $65.52 | $287,771.75 |
DisclosureSEC source: 0001193125-26-091757 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,197 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:09 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,256 | $62.86 | $204,672.16 |
DisclosureSEC source: 0001193125-26-055630 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,589 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 00:40 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 25,500 | $0.00 Strike: $74.75 | $0.00 |
DisclosureSEC source: 0001193125-26-047193 · ownership.xml · derivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 25,500 shares Expires 2036-02-09 F2 · derivative.exercise_date: The shares underlying this option shall vest in 48 equal monthly installments beginning on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 00:40 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047193 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,845 F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 22, 2025 Filed Dec 30, 2025 01:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 99 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001193125-25-335678 · ownership.xml · derivative · entry 6 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,905 Underlying: Common Stock · 99 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 22, 2025 Filed Dec 30, 2025 01:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 219 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001193125-25-335678 · ownership.xml · derivative · entry 5 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,628 Underlying: Common Stock · 219 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof Read SEC document |
| December 22, 2025 Filed Dec 30, 2025 01:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,825 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001193125-25-335678 · ownership.xml · derivative · entry 4 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,550 Underlying: Common Stock · 2,825 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof Read SEC document |
| December 22, 2025 Filed Dec 30, 2025 01:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 99 | $13.50 | $1,336.50 |
DisclosureSEC source: 0001193125-25-335678 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 30, 2025 01:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 219 | $9.86 | $2,159.34 |
DisclosureSEC source: 0001193125-25-335678 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 30, 2025 01:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 2,825 | $9.86 | $27,854.50 |
DisclosureSEC source: 0001193125-25-335678 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 02:31 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 300 | $92.23 | $27,669.00 |
DisclosureSEC source: 0001193125-25-321440 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,702 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2025. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 02:31 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 9,151 | $91.44 | $836,724.43 |
DisclosureSEC source: 0001193125-25-321440 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,002 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.03 to $91.99, inclusive. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 02:31 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,642 | $90.60 | $329,978.68 |
DisclosureSEC source: 0001193125-25-321440 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,153 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.02 to $90.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 20:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,411 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-25-092302 · ownership.xml · derivative · entry 4 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,847 Underlying: Common Stock · 2,411 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following July 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 20:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 29,659 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-25-092302 · ownership.xml · derivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,375 Underlying: Common Stock · 29,659 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 20:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 2,411 | $9.86 | $23,772.46 |
DisclosureSEC source: 0000950170-25-092302 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 20:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 29,659 | $9.86 | $292,437.74 |
DisclosureSEC source: 0000950170-25-092302 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 00:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,996 | $50.00 | $149,800.00 |
DisclosureSEC source: 0000950170-25-084034 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,725 F1 · kind: The transaction reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on January 23, 2025. Read SEC document |
| May 20, 2025 Filed May 22, 2025 22:31 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 6,677 | $50.04 | $334,128.43 |
DisclosureSEC source: 0000950170-25-076525 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,721 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 02, 2025 Filed May 7, 2025 00:53 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,100 | $50.17 | $105,367.08 |
DisclosureSEC source: 0000950170-25-064843 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,398 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.06 to $50.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 00:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,638 | $54.58 | $89,402.04 |
DisclosureSEC source: 0000950170-25-024474 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,498 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units granted on January 10, 2024 and previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0000950170-25-019085 · ownership.xml · derivative · entry 6 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2035-02-09 F4 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-019085 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,136 F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 12, 2025 23:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,498 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-25-019085 · ownership.xml · derivative · entry 5 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,498 shares Expires 2030-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 2,140 shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 38 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 12, 2025 23:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,233 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-25-019085 · ownership.xml · derivative · entry 4 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,233 shares Expires 2030-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 12, 2025 23:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 1,498 | $2.65 | $3,969.70 |
DisclosureSEC source: 0000950170-25-019085 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2025 Filed Feb 12, 2025 23:33 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 4,233 | $2.65 | $11,217.45 |
DisclosureSEC source: 0000950170-25-019085 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,920 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · derivative · entry 7 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,004 Underlying: Common Stock · 8,920 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F6 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,263 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · derivative · entry 6 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,258 Underlying: Common Stock · 5,263 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F5 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following July 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,904 | $67.02 | $127,612.74 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · nonDerivative · entry 5 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,405 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.44 to $67.32, inclusive. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 3,542 | $65.79 | $233,017.55 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · nonDerivative · entry 4 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,309 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.44 to $66.41, inclusive. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 8,737 | $64.98 | $567,696.19 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,851 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 8,920 | $13.50 | $120,420.00 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 01:03 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 5,263 | $9.86 | $51,893.18 |
DisclosureSEC source: 0000950170-24-131211 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 23:46 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,158 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-24-128925 · ownership.xml · derivative · entry 5 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,034 Underlying: Common Stock · 9,158 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F4 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 23:46 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 100 | $61.10 | $6,110.00 |
DisclosureSEC source: 0000950170-24-128925 · ownership.xml · nonDerivative · entry 4 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,405 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 23:46 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,219 | $60.16 | $73,332.85 |
DisclosureSEC source: 0000950170-24-128925 · ownership.xml · nonDerivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,505 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.92 to $60.54, inclusive. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 23:46 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 7,839 | $59.54 | $466,709.76 |
DisclosureSEC source: 0000950170-24-128925 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,724 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.91 to $59.905, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 23:46 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 9,158 | $9.86 | $90,297.88 |
DisclosureSEC source: 0000950170-24-128925 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:05 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,500 | $47.41 | $71,115.00 |
DisclosureSEC source: 0000950170-24-107769 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,405 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:05 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,500 | $50.59 | $75,885.00 |
DisclosureSEC source: 0000950170-24-103385 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,905 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023. Read SEC document |
| April 10, 2024 Filed Apr 11, 2024 21:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,777 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-24-043769 · ownership.xml · derivative · entry 3 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,498 Underlying: Common Stock · 8,777 shares Expires 2030-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 2,140 shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 38 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| April 10, 2024 Filed Apr 11, 2024 21:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,093 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-24-043769 · ownership.xml · derivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,233 Underlying: Common Stock · 13,093 shares Expires 2030-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| April 10, 2024 Filed Apr 11, 2024 21:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 21,870 | $2.65 | $57,955.50 |
DisclosureSEC source: 0000950170-24-043769 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2024 Filed Mar 2, 2024 00:36 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 27,800 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0000950170-24-024187 · ownership.xml · derivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,800 Underlying: Common Stock · 27,800 shares Expires 2034-01-09 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 10, 2024 Filed Mar 2, 2024 00:36 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 18,535 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024187 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,535 Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 20:06 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-043894 · ownership.xml · derivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,326 Underlying: Common Stock · 3,000 shares Expires 2030-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.